摘要
目的分析参松养心胶囊与比索洛尔治疗心律失常的临床治疗效果。方法选取2007年5月至2011年12月期间,采用参松养心胶囊治疗的心律失常患者50例,作为A组;选取采用比索洛尔治疗的心律失常患者50例,作为B组;再选取采用参松养心胶囊联合比索洛尔治疗的心律失常患者50例,作为C组。将三组患者临床症状、心电图动态的变化情况,以及生活质量评分情况进行对比分析,从而总结参松养心胶囊与比索洛尔治疗心律失常的临床治疗效果。结果 A组患者临床症状、心电图动态的变化情况,以及生活质量评分情况均明显好于B组患者,而C组患者临床症状、心电图动态的变化情况,以及生活质量评分情况明显好于A组。结论参松养心胶囊治疗心律失常比比索洛尔更加有效,参松养心胶囊联合比索洛尔治疗心律失常比参松养心胶囊更加有效。
Objective To analyze the effect of Shensongyangxin capsule and bisoprolol on arrhythmia clinical treatment effect. Methods from 2007May to 2011December, using Shensongyangxin capsule in the treatment of patients with cardiac arrhythmias in 50 patients, as the A group, select the use of Bisoprolol for treatment of arrhythmia in patients with 50 cases, as the B group, then select the Shensongyangxin capsule combined with bisoprolol treated patients with arrhythmia in 50 cases, as the C group the three groups of patients, clinical symptoms, electrocardiographic changes, and quality of life score condition carries on the contrast analysis to summarize, Shensongyangxin capsule and bisoprolol on arrhythmia clinical treatment effect. Results In group A patients with clinical symptoms, electrocardiogram changes, and quality of life score is significantly better than the patients in group B, group C patients with clinical symptoms, electrocardiogram dynamic changes, as well as the quality of life score significantly better in group A. Conclusion The therapeutic effect of Shensongyangxin capsule on cardiac arrhythmia Bibi bisoprolol more effective, Shensongyangxin capsule combined with bisoprolol on arrhythmia of Shensongyangxin capsule is more effective than.
出处
《中国医药指南》
2012年第23期80-81,共2页
Guide of China Medicine